A biopharmaceutical company has been ordered to pay more than $85,000 in restitution to Kansas consumers following an investigation into the company’s business and advertising practices involving its copayment coupon program, Attorney General Derek Schmidt said today. The settlement resolves allegations that Pfizer, Inc., deceptively marketed its copayment coupon program for its Estring, Quillivant XR and Quillichew ER (“Quillivant”), and Flector Patch products. Pfizer distributed coupons promising consumers would pay “no more than $15 or $20,” for example, for prescriptions without clearly and conspicuously disclosing the material terms and conditions as required by the Kansas Consumer Protection Act.